The Lancet. Digital healthHumansLymphocytesTumor-InfiltratingFemaleBreast Neoplasms
Label-efficient computational tumour infiltrating lymphocyte assessment in breast cancer (ECTIL): multicentre validation in 2340 patients with breast cancer.
Yoni Schirris, Rosie Voorthuis, Mark Opdam, Marte Liefaard, Gabe S Sonke, Gwen Dackus, Vincent de Jong, Yuwei Wang, Annelot Van Rossum, Tessa G Steenbruggen, Lars C Steggink, Elisabeth G E de Vries, Marc van de Vijver, Roberto Salgado, Efstratios Gavves
Published: 202510.1016/j.landig.2025.100921
Abstract
BACKGROUND: The density of stromal tumour-infiltrating lymphocytes (TILs) is a prognostic factor for patients with triple-negative breast cancer and reflects their immune response. Computational TIL assessment has the potential to assist pathologists…
Preview only. Read the full abstract at the source